Valiant Laboratories Rights Issue dates 28 July – 8 August 2025.
Incorporated in 1980, Valiant Laboratories (VLL) is a pharmaceutical and specialty chemical manufacturer primarily engaged in the production of Active Pharmaceutical Ingredients (APIs). The company specializes in the manufacturing of paracetamol API, a widely used analgesic and antipyretic agent. VLL also produces finished dosage forms including tablets, capsules, and other formulations based on paracetamol.
The Paracetamol API manufactured by VLL is essential for treating common conditions such as headaches, arthritis, muscle pain, toothaches, back pain, colds, and fevers. The product is offered in multiple grades and physical forms—powder, fine powder, and crystals—to cater to diverse industrial and therapeutic applications.
VLL operates a GMP-compliant and ISO 9001:2015 certified manufacturing facility located in Palghar, Maharashtra, with an installed production capacity of 9,000 metric tonnes per annum (MTPA). This facility supports high-quality, scalable production, meeting both domestic and international regulatory standards.
Promoters of Valiant Laboratories – Paresh Shashikant Shah, Santosh Shantilal Vora, Shantilal Shivji Vora, Rachi Santosh Vora, Kanchan Shantilal Vora, Varsha Paresh Shah, Sangita Manoj Jain, and Dhanvallabh Ventures LLP
Table of Contents
Valiant Laboratories Rights Issue Details
| Valiant Laboratories Rights Issue Date | 28 July – 8 August 2025 |
| Valiant Laboratories Rights Issue Price | INR 75 per share |
| Issue Size (in Shares) | 1,08,62,500 shares |
| Issue Size (in INR) | INR 81.47 crore |
| Issue Entitlement | 1 equity share for every 4 equity shares held on the record date |
| Terms of Payment | Fully payable at the time of application |
| Valiant Laboratories Rights Issue Record Date | 19 July 2025 |
| Face Value | INR 10 per share |
| Listing On | BSE, NSE |
Valiant Laboratories Rights Issue Calculation
| Valiant Laboratories Rights Issue Price | INR 75 per share |
| Market Price on Rights Issue Approval | INR 115.2 per share |
| Dilution Factor (X) | 1.25 |
| Fair Value After Dilution at Prevailing Price | INR 107.16 per share |
Valiant Laboratories Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Revenue | 334 | 182 | 133 |
| Expenses | 299 | 190 | 138 |
| OPM (%) | 11.0 | (5.0) | (4.0) |
| Net Income | 29.0 | 0.0 | (2.0) |
| ROCE (%) | – | (2.0) | (0.0) |
Valiant Laboratories Rights Offer Objectives
The net proceeds from the offer are proposed to be used for
- Adjustment of unsecured loans of promoter/promoter group towards rights equity shares application money – INR 58.01 crore
- Repayment of outstanding loans of existing promoters Dhanvallabh Ventures LLP – INR 1.40 crore
- Capital Expenditure – INR 1.80 crore
- General corporate purposes – INR 19.56 crore
Valiant Laboratories Rights Offer Documents
- Valiant Laboratories Rights Issue Application Form
- Valiant Laboratories Letter of Offer
- Board Meeting Outcome
- Valiant Laboratories Draft Letter of Offer
- Rights Issue in 2024
Valiant Laboratories Rights Issue Dates
| Rights Issue Approval Date | 15 July 2025 |
| Rights Issue Record Date | 19 July 2025 |
| Credit of Rights Entitlement | 21 July 2025 |
| Rights Issue Opening Date | 28 July 2025 |
| Last Date for Market Renunciation | 5 August 2025 |
| Rights Issue Closing Date | 8 August 2025 |
| Finalization of Basis of Allotment | 11 August 2025 |
| Rights Allotment Date | 11 August 2025 |
| Credit Date | 12 August 2025 |
| Listing Date | 13 August 2025 |
Valiant Laboratories Rights Offer Registrar
MUFG INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Telephone: +91 810 811 4949
Email: [email protected]
Website: www.linkintime.co.in
Valiant Laboratories Contact Details
VALIANT LABORATORIES LIMITED
104, Udyog Kshetra, Mulund Goregoan Link Road
Mulund West, Mumbai City, Mumbai, Maharashtra, 400080
Phone: +91-22-4971 2001
Email: [email protected]
Website: www.valiantlabs.in
Valiant Laboratories Rights Offer FAQs
What is the Valiant Laboratories Rights Issue Price?
The issue price is INR 75 per share.
What is the Valiant Laboratories Rights Issue entitlement ratio?
The eligible shareholders are offered 1 equity share for every 4 equity shares held on the record date.
What is the Valiant Laboratories Rights Issue Record Date?
The Record date is 19 July 2025.
How to Apply in the Valiant Laboratories Rights Offer?
The best way to apply in the Valiant Laboratories Rights Offer is through Internet banking ASBA. You can also apply online through your stockbroker using UPI. If you prefer to make paper applications, fill up an application form and deposit the same to your broker.